Rubicon Fund II LP 13D/13G Filings for Evolent Health, Inc. (EVH)

Rubicon Fund II LP 13D and 13G filings for Evolent Health, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-14
5:26 pm
Purchase
2025-11-1313GEvolent Health, Inc.
EVH
Rubicon Fund II LP5,816,123
5.210%
5,816,123increase
(New Position)
Filing